AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Galantamine Hydrobromide Equivalent To Galantamine
17 registrations across 1 African market— 10 active
Markets with Galantamine Hydrobromide Equivalent To Galantamine
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| REMINYL 4 mg/ml | 🇿🇦South Africa | Janssen Pharmaceutica (Pty) Ltd | suspended | Dec 2022 |
| NAMATE 4 mg TABLETS | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | suspended | Nov 2022 |
| NAMATE 8 mg TABLETS | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | suspended | Nov 2022 |
| ALANTA 4 mg | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | suspended | Nov 2022 |
| ALANTA 12 mg | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | suspended | Nov 2022 |
| NAMATE 12 mg TABLETS | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | suspended | Nov 2022 |
| ALANTA 8 mg | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | suspended | Nov 2022 |
| MYLAN GALANTAMINE 4 | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | active | Jan 1900 |
| MYLAN GALANTAMINE 12 | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | active | Jan 1900 |
| ALZERMEG 12 | 🇿🇦South Africa | Biotech Laboratories (Pty) Ltd | active | Jan 1900 |
| REMINYL CR 8 mg | 🇿🇦South Africa | Janssen Pharmaceutica (Pty) Ltd | active | Jan 1900 |
| MYLAN GALANTAMINE 8 | 🇿🇦South Africa | Viatris South Africa (Pty) Ltd | active | Jan 1900 |
| REMCEPT XL 16 mg | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| GALANTAMINE 4 BIOTECH | 🇿🇦South Africa | Biotech Laboratories (Pty) Ltd | active | Jan 1900 |
| REMCEPT XL 24 mg | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| REMCEPT XL 8 mg | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| GALANTAMINE 8 BIOTECH | 🇿🇦South Africa | Biotech Laboratories (Pty) Ltd | active | Jan 1900 |
Galantamine Hydrobromide Equivalent To Galantamine in Africa — Regulatory Overview
Galantamine Hydrobromide Equivalent To Galantamine is registered across 1 African markets with 17 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 17 registrations, 10 (59%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.